North America Nasal Delivery Devices Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis by Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, and Others); Delivery Technologies (Spray, Nebulizers, Inhalers, and Others); End User (Home Care Settings, Hospitals, and Clinics); and Country

No. of Pages: 122
Report Code: TIPRE00018194
Category: Life Sciences
North America Nasal Delivery Devices Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Nasal Delivery Devices Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Nasal Delivery Devices Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Nasal Delivery Devices Market Regional Analysis

6.2 North America Nasal Delivery Devices Market Revenue 2017-2027 (US$ Million)
6.3 North America Nasal Delivery Devices Market Forecast Analysis

7. North America Nasal Delivery Devices Market Analysis – by Drug Type

7.1 Anaesthetics
  • 7.1.1 Overview
  • 7.1.2 Anaesthetics: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Antibiotics
  • 7.2.1 Overview
  • 7.2.2 Antibiotics: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Pain Relief Drugs
  • 7.3.1 Overview
  • 7.3.2 Pain Relief Drugs: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Calcium Supplements
  • 7.4.1 Overview
  • 7.4.2 Calcium Supplements: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Vasoconstrictors
  • 7.5.1 Overview
  • 7.5.2 Vasoconstrictors: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Antihistamines
  • 7.6.1 Overview
  • 7.6.2 Antihistamines: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Nasal Delivery Devices Market Analysis – by Delivery Technologies

8.1 Spray
  • 8.1.1 Overview
  • 8.1.2 Spray: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Nebulizers
  • 8.2.1 Overview
  • 8.2.2 Nebulizers: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Inhalers
  • 8.3.1 Overview
  • 8.3.2 Inhalers: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Nasal Delivery Devices Market Analysis – by End User

9.1 Home Care Settings
  • 9.1.1 Overview
  • 9.1.2 Home Care Settings: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Hospitals
  • 9.2.1 Overview
  • 9.2.2 Hospitals: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Clinics
  • 9.3.1 Overview
  • 9.3.2 Clinics: North America Nasal Delivery Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America Nasal Delivery Devices Market – North America Analysis

10.1 Overview

10.2 North America
  • 10.2.1 North America Nasal Delivery Devices Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.2.1.1 North America Nasal Delivery Devices Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 US: North America Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.1.1 US: North America Nasal Delivery Devices Market Breakdown, by Drug Type
    • 10.2.1.1.2 US: North America Nasal Delivery Devices Market Breakdown, by Delivery Technologies
    • 10.2.1.1.3 US: North America Nasal Delivery Devices Market Breakdown, by End User
  • 10.2.1.2 Canada: North America Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.2.1 Canada: North America Nasal Delivery Devices Market Breakdown, by Drug Type
    • 10.2.1.2.2 Canada: North America Nasal Delivery Devices Market Breakdown, by Delivery Technologies
    • 10.2.1.2.3 Canada: North America Nasal Delivery Devices Market Breakdown, by End User
  • 10.2.1.3 Mexico : North America Nasal Delivery Devices Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.2.1.3.1 Mexico : North America Nasal Delivery Devices Market Breakdown, by Drug Type
    • 10.2.1.3.2 Mexico : North America Nasal Delivery Devices Market Breakdown, by Delivery Technologies
    • 10.2.1.3.3 Mexico : North America Nasal Delivery Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 GlaxoSmithKline plc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 AstraZeneca
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Pfizer Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BD
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Sanofi
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Merck & Co., Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Cadila Pharmaceuticals Ltd.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Novartis AG
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Dr. Reddy's Laboratories
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Neurelis, Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - North America Nasal Delivery Devices Market

  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc.
  • BD
  • Sanofi
  • Merck & Co., Inc.
  • Cadila Pharmaceuticals Ltd.
  • Novartis AG
  • Dr. Reddy's Laboratories
  • Neurelis, Inc.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)